News

MatchBio spinout set to revolutionise immunotherapy

29th July 2024

All News | Spinouts & Startups

A new company, MatchBio, founded by Professors Omer Dushek and Anton van der Merwe from the Dunn School of Pathology, is set to revolutionise immunotherapy by enhancing CAR T therapy.

Apollo Therapeutics and the University of Oxford enter into drug discovery and development collaboration

22nd July 2024

All News

Apollo Therapeutics will inject capital and expertise into pipeline of potentially lifesaving medicines through an agreement with the University of Oxford. The collaboration highlights a shared strategic intent to develop new therapeutics based on breakthroughs in biology and basic medical research at the University of Oxford.

Image from Oxford Semantic Technologies – an Oxford University spinout specialising in knowledge graph and reasoning technology – acquired by Samsung Electronics News Article

Oxford Semantic Technologies – an Oxford University spinout specialising in knowledge graph and reasoning technology – acquired by Samsung Electronics

18th July 2024

All News | Spinouts & Startups

An Oxford University spinout which supports accurate AI applications using Knowledge & Reasoning has been bought by Samsung Electronics.

Oxford Innovation Society (OIS)

18th July 2024

All News | Spinouts & Startups

Oxford University Innovation recently hosted two landmark events that brought together global investors, leading industry experts and innovative spinouts, showcasing the vibrant ecosystem of collaboration and cutting-edge technology at Oxford.

Tech transfer partnership between universities creates company to transform care for millions of women

18th July 2024

All News | Financial News | Partners | Spinouts & Startups | Technology News

Amber Therapeutics successfully closed Series A funding of $100 million (£80 million) from leading healthcare and technology investors in the US and UK.

Enhancing clinical trials: The vital role of Clinical Outcome Assessments

17th July 2024

All News | Clinical Outcomes

Discover why Clinical Outcome Assessments (COAs) are vital in clinical trials for measuring patient outcomes and ensuring reliable data for regulatory approval and improved patient care.

A StEP in the right direction

16th July 2024

All News | Startup Incubator

OUI's StEP Ignite student entrepreneurship programme 2024

Yellowstone Biosciences spinout launches to advance cutting-edge cancer therapies from University of Oxford research

12th July 2024

All News | Spinouts & Startups

Yellowstone Biosciences, a biotechnology spinout, has launched to pioneer new cancer treatments using advanced T-cell therapies based on groundbreaking research from the MRC Weatherall Institute of Molecular Medicine at University of Oxford.

Oxford Ionics and the race towards quantum computers

12th July 2024

All News | Spinouts & Startups

Dr Chris Ballance, co-founder and CEO of quantum computing spinout Oxford Ionics talks about the commercial challenges, successful funding rounds, and future collaborations.

Introducing the recipients of the 2024 Jamie Ferguson Innovation Awards

5th July 2024

All News

The third year of the Jamie Awards featured ideas such as cleaner hydrogen use in chemical production, an agrochemical for improving crop resilience to floods, advancements in materials for safer and more efficient batteries, and the development of new medical treatments using 3D printing.

News

Ready to get in touch?